Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symptomatic Management of Lyme Arthritis
NCT04038346Phase 3Terminated
- Start
- Oct 2019
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naproxen in Lyme arthritis (LA). Started Oct 2019; status: terminated.
02
Drugs
naproxen
03
Conditions
Lyme arthritis (LA)
Beyond the preview
Go deeper on NCT04038346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04038346.